The effects of dimethyl fumarate and fingolimod on T-cell lymphocyte proliferation in patients with multiple sclerosis

OBJECTIVE: The disease-modifying therapies (DMT), dimethyl fumarate (DMF) and fingolimod (FTY) improve the outcomes in multiple sclerosis (MS) by reducing relapses and numbers and volume of lesions. They mediate their effects through reduction of immune reactivation, which may potentially lead to ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynolds, Audrey, Gaughan, Maria, Holden, Dean, Redenbaugh, Vyanka, Dunne, Jean, Redmond, Janice, Conlon, Niall
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672000/
https://www.ncbi.nlm.nih.gov/pubmed/35028898
http://dx.doi.org/10.1007/s11845-021-02913-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672000/
https://www.ncbi.nlm.nih.gov/pubmed/35028898
http://dx.doi.org/10.1007/s11845-021-02913-8

Ejemplares similares